Relay Therapeutics CEO Patel files Form 144 for 96,401 shares
Form 144 filed with the SEC by Relay Therapeutics CEO Patel Sanjiv to register restricted shares for sale; the filing lists 96,401 shares and an approximate sale date of 10/7/2026.
Form 144 filed with the SEC by Relay Therapeutics CEO Patel Sanjiv to register restricted shares for sale; the filing lists 96,401 shares and an approximate sale date of 10/7/2026.